The Oxford-AstraZeneca vaccine is best suited for Africa according to Professor of Vaccinology at the University of the Witwatersrand, Shabir Madhi.
Professor Madhi is leading the clinical trial of the vaccine locally.
He said the vaccine isn’t only effective but also affordable.
The Oxford vaccine is so far reported to have a good safety record with no serious side-effects.
The ongoing late-stage trial is taking place at 150 global sites in the US, Germany, Turkey, South Africa, Brazil and Argentina.
Sustainable Corporate Travel: A New Take On Travelling Light
Joburg Water Blames Constant Power Failures For Water Crisis
Gassing Up Western Cape Grid
Cosatu Wants Answers From Government Over Bester Escape
Ramokgopa Highlights Design Flaws In Medupi Construction
Thabo Bester Did Not Die In A Fire But Escaped From Prison – DCS
SA Won’t Go Beyond Stage 6 Power Cuts – Ramokgopa
World TB Day – Yes! We Can End TB
Medical Fees Rise By 5.3% In February – Stats SA
Power Cuts Case Continues
Ramokgopa Tours Troubled Tutuka
EFF’s No-Confidence Motion Against Speaker Fails